A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.There is no 510(k) for this device as it is manufactured outside the u.S.And not sold in the u.S.But is considered to be substantially similar to the legally u.S.Marketed device bd bbl¿ cdc anaerobe 5% sheep blood agar catalog number 221733 which has 510k number k803025.
|
H.6.Investigation: this statement is to summarize findings on the recent complaint against plate cdc anaerobe agar 5% sb, catalog number 256506, lot number 1307556 with respect to contamination.Event description: it was reported some plates being affected by contamination with colonies.Complaint history review: the complaints trends were reviewed.There was no similar complaints received on this batch number.Therefore, a trend could not be identified.Batch history record (bhr) review: the batch history review did not indicate any discrepancies.All release testing was satisfactory and no deviations were observed.Sample analysis: no samples provided; but the shared pictures were showing the reported contamination on the plates.Evaluation results: at this stage of our investigation, we have excluded any systemic failure in our manufacturing process.Please note that this product does not have an sal claim.It is filled aseptically, therefore an occurrence of a contamination event cannot be entirely ruled out.Please note that the valid standard for these products is din en 12322 "in vitro diagnostic medical devices - culture media for microbiology".According to this standard the contamination rate for each product lot must not exceed 4.9 %.For our continuous monitoring, we derive a contamination ratio for below this specified value.According to our high quality standard, we only release product batches to the market with an aql (acceptable quality level) = 1.5.Although this contamination level is very low, we cannot completely exclude that a customer may receive a contaminated plate.Investigation conclusion: based upon our investigation and the report and picture provided, the complaint could be confirmed.A corrective and preventive action will not be implemented as a trend could not be identified.A definite root cause could not be determined.We would suggest to set aside, and not use, any prepared plated media that does not meet the appearance specification as it is described on the bd certificate of analysis.This is consistent with industry recommendations for inspection of culture media prior to use (e.G.¿good practices for pharmaceutical microbiology laboratories¿, who technical report series, no.961, 2011, annex 2; chapter <1117> ¿microbiology best laboratory practices¿ the united states pharmacopeia; and the difco & bbl manual).
|